|
(P480) |
Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure |
| |
|
X. Wu, T. Yang, Q. Zhou, S. Li, L. Huang (China, CN) |
|
(P481) |
Haemodynamic effects of acute PDE-5A inhibition in a porcine model of hypertensive heart disease |
| |
|
A. Alogna, M. Schwarzl, B. Zirngast, M. Manninger-Wünscher, D. Zweiker, J. Verderber, P. Steendijk, H. Mächler, B. Pieske, H. Post (Graz, AT; Hamburg; Leiden, NL) |
|
(P482) |
Haemodynamic effects of acute stimulation of soluble guanylate cyclase in a porcine model of hypertensive heart disease |
| |
|
A. Alogna, M. Schwarzl, B. Zirngast, M. Manninger-Wünscher, D. Zweiker, J. Verderber, P. Steendijk, H. Mächler, B. Pieske, H. Post (Graz, AT; Hamburg; Leiden, NL) |
|
(P483) |
Long-term Outcome of Patients Eligible for CRT-D after ICD-only Implantation in Relation to Responders/Non-responders to CRT-D |
| |
|
J. Keppler, J. Franke, A. Karimi, A. Bajrovic, L. Meme, P. Raake, C. Zugck, H. A. Katus, L. Frankenstein (Heidelberg, Dossenheim, Straubing) |
|
(P484) |
Low exercise tolerance in heart failure patients with and without cardiac cachexia: echocardiographic and hemodynamic predictors |
| |
|
M. Valentova, S. von Haehling, T. Bekfani, L. Steinbeck, N. Ebner, J. Murin, S. D. Anker, A. Sandek , SICA-HF (Berlin; Bratislava, SK) |
|
(P485) |
Percutaneous balloon occlusion of a left ventricular assist device outflow cannula during right heart catheterization with pumpstop as part of the evaluation of myocardial recovery |
| |
|
J. Vierecke, M. Dandel, S. Dreysse, P. Stawowy, E. Potapov, T. Krabatsch, R. Hetzer (Berlin) |
|
(P486) |
Low bone mineral density as a risk marker for incident heart failure: a prospective population-based cohort study |
| |
|
R. Pfister, G. Michels, S. Sharp, R. Luben, N. Wareham, K.-T. Khaw (Köln; Cambridge, UK) |
|
(P487) |
Autoantibodies against the Thrombin receptor (PAR-1) are substantially reduced in patients with heart failure: results from the CIBIS-ELD trial |
| |
|
R. Dechend, R. Wachter, S. Störk, D. Obradovic, D. Dragun, A. Busjahn, G. Riemekasten, E. Tahirovic, B. Pieske, T. D. Trippel, H. Heidecke, D. Mueller, H.-D. Düngen (Berlin, Göttingen, Würzburg, Luckenwalde; Graz, AT) |
|
(P488) |
ICD therapy in patients with LVAD: is there an interaction? |
| |
|
V. Seifert, D. Schmitz, N. Pizanis, M. Kamler, C. K. Naber, O. Bruder (Essen) |